Published in Obesity and Diabetes Week, May 22nd, 2006
"Further investigations are warranted to better characterize variables that may confound the clinical interpretation of plasma natriuretic peptide measurements, which are increasingly recognized to have diagnostic and predictive importance," scientists in the United States report.
J.V. St. Peter and colleagues at the University of Minnesota explained, "Blood samples (EDTA plasma) from patients (n=206) attending clinics for the medical treatment and follow-up of obesity were analyzed for B-type natriuretic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.